Paper37541540
Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges.
Wang W and 4 others. Cancer Lett, 2023. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges. Papers, record 37541540. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37541540
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Curcumin | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Apoptosis | |
| Immunotherapy |
Source PubMed
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891328 | Autophagy-Modulating Nanomedicine for Glioma: Delivery Barriers, Lysosomal Interactions, and a Flux-Resolved Translational Decision Framework. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42891328 | PubMed |
| 42885231 | Synthesis of Curcumin Analogs Targeting Androgen Receptor for the Selective Inhibition of Castration-Resistant Prostate Cancer Cells. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42885231 | PubMed |
| 42655109 | Curcumin Pretreatment Alleviates Early Mannheimia Haemolytica-Induced Pulmonary Injury in Mice and Is Associated with Changes in Gut Microbial Composition. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655109 | PubMed |
| 42573911 | Effect of Polyphenols Derived from Medicinal Plants on Multiple Myeloma via Modulating Bone Marrow Microenvironment. | Chin J Integr Med | 2026 | https://conductscience.org/library/papers/42573911 | PubMed |
| 42514903 | Curcumin as a Synergy Amplifier in Cancer Therapy. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514903 | PubMed |
| 42506735 | Curcumin Precisely Regulates Ochratoxin A-Induced Apoptosis in Porcine Renal Epithelial Cells via the PI3K/AKT/mTOR Signaling Pathway. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42506735 | PubMed |
| 42410284 | Curcumin Attenuates Cuproptosis via Activating Autophagy Through Inhibition of the AKT/mTOR/P70S6K-Signaling Pathway in Parkinson's Disease Models. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42410284 | PubMed |
| 42231363 | Celastrol induces apoptosis of myelodysplastic syndrome cells through a ROS-dependent pro-apoptotic endoplasmic-reticulum stress pathway. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42231363 | PubMed |
| 42226962 | Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42226962 | PubMed |
| 42218339 | Integrated proteomic and single-nucleus transcriptomic profiling identifies prognostic markers and therapeutic targets in glioblastoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42218339 | PubMed |
| 42212375 | Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/42212375 | PubMed |
| 42192945 | Extracellular Vesicle-Mediated Delivery of Curcumin Suppresses Tumor Progression in Murine Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42192945 | PubMed |
| 42176148 | Nature meets immunity: curcumin's role in modulating neutrophil extracellular traps. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42176148 | PubMed |
| 41993589 | Bioactive plant and fungal metabolites in oral cancer: molecular mechanisms and translational potential. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41993589 | PubMed |
| 41969587 | Curcumin induces and enhances the PARP1-mediated parthanatos in diffuse large B cell lymphoma. | Oncol Lett | 2026 | https://conductscience.org/library/papers/41969587 | PubMed |
| 41852897 | Leucovorin enhances curcumin-induced inhibition of cell viability and ferroptosis in colorectal cancer cells. | Oncol Lett | 2026 | https://conductscience.org/library/papers/41852897 | PubMed |
| 41843303 | Autophagy and Lysosomal Dysregulation in Endometriosis: Therapeutic Opportunities and Molecular Insights. | Reprod Sci | 2026 | https://conductscience.org/library/papers/41843303 | PubMed |
| 41815641 | Curcumin induces apoptosis in osteosarcoma cells by regulating the glycolytic pathway via the MAPK axis: a mechanistic study. | Open Life Sci | 2026 | https://conductscience.org/library/papers/41815641 | PubMed |
| 41751777 | Development of a Curcumin-Loaded Nanomicelles-Injectable Sustained-Release Hydrogel System for Modulating Oxidative Stress to Alleviate Tendinopathy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751777 | PubMed |
| 41695302 | Advances in targeting vasculogenic mimicry in malignant tumors using monomeric compounds from Traditional Chinese Medicine (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/41695302 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37541540
GET https://conductscience.org/api/papers/v1/37541540/cited_by?page=2